Immunogenetics: A Molecular and Clinical Overview, Vol. 3

Immune Cells and Immunotherapeutics in Recurrent Miscarriage
Erscheinungsjahr 2025
ISBN: 978-0-443-13617-7
Verlag: Elsevier Health Sciences

Buch, Englisch, 350 Seiten, Format (B × H): 191 mm x 235 mm

Immunogenetics: A Molecular and Clinical Overview, Vol. 3, Immune Cells and Immunotherapeutics in Recurrent Miscarriage provides an overview of the scientific knowledge, achievements, and findings in the field of immunogenetics of recurrent pregnancy loss. With a strong focus on the role immune cells can play in recurrent pregnancy loss, the book also examines immune therapeutic aspects. In fifteen chapters, the book describes the roles of both helper cells, nature killer cells, lymphoid cells, regulatory cells and macrophages in recurrent pregnancy loss. In addition, it describes clinical outcomes of several therapies and gives insight into new treatments. This new release is a valuable resource for health professionals, scientists and researchers, and all those who wish to broaden their knowledge in the allied field.

Autoren/Hrsg.

Ali, Shafat

U Rehman, Muneeb

Taing, Shahnaz

Arafah, Azher

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie

Inhaltsverzeichnis

1. Role of CD4+ T helper cells (Th1, Th2 and Th17 cells) in Recurrent pregnancy loss
2. Role of Nature Killer and Innate lymphoid cells in Recurrent pregnancy loss
3. Role of T Regulatory in Recurrent pregnancy loss
4. Role of CD8+ Cytotoxic T cells in Recurrent pregnancy loss
5. Role of B cells, macrophages and dendritic cells in Recurrent pregnancy loss
6. Clinical outcome of Low molecular weight heparin and aspirin therapy in Recurrent pregnancy loss patients
7. Clinical outcome of Intravenous immunoglobulin (IVIg) therapy in Recurrent pregnancy loss patients
8. Vitamin D3 therapy and clinical outcome in Recurrent pregnancy loss patients
9. Efficacy of Intralipid infusion therapy in the treatment of Recurrent pregnancy loss patients
10. Therapeutic potential of Cyclosporine A in Recurrent pregnancy loss
11. Progesterone therapy and clinical outcome in Recurrent pregnancy loss patients
12. Granulocyte-Colony Stimulating Factor (G-CSF) therapy in Recurrent pregnancy loss patients
13. Lymphocyte immunotherapy (LIT) and clinical outcome in Recurrent pregnancy loss patients
14. TNFa inhibition and treatment of Recurrent pregnancy loss
15. Genetic counselling and clinical pregnancy outcome
16. Importance of evidence-based medical treatments for Recurrent pregnancy loss
17. Evidence-based new developments in reproductive immunogenetics and future perspectives

Über Autor(innen)

Taing, Shahnaz
Shahnaz Taing (MBBS, MD) has served as Head and Professor at the Department of Obstetrics and Gynaecology, Government Medical College, Srinagar. She has completed her MBBS in 1989 at Government Medical College, Srinagar affiliated to University of Kashmir, Srinagar. She has an experience of more than 30 years as medical practitioner, teacher and researcher. She is the recipient of several awards. Prof. Taing is a Life Member of many Medical associations. She also has to her credit numerous research publications in peer-reviewed international journa

Ali, Shafat
Shafat Ali (Ph.D.) pursued his BSc. from University of Kashmir and Masters in Zoology from Barkatullah Vishwavidyalaya, India. Currently he is engaged in research work for last 5 years at Cytogenetics and Molecular Biology Laboratory, Centre of Research for Development, University of Kashmir, Department of Biochemistry, Government Medical College, Srinagar, Jammu and Kashmir, and ICMR funded Multidisciplinary Research Unit, Government Medical College, Srinagar, Jammu and Kashmir, India, with specialization in the field of reproductive immunogenetics, cytokine biology, gynaecology and obstetrics, molecular biology, cancer biology and cytogenetics. He has 5 years of research experience and 5 years of teaching experience. He has more than 20 book chapters, several edited books and numerous peer-reviewed, international research publications to his credit. Mr. Ali is also the reviewer of many reputed international journals. Presently, Mr. Ali is involved in studying immunogenetic mechanisms involved in recurrent pregnancy loss

Arafah, Azher
Azher Arafah works in the Department of Clinical Pharmacy, College of Pharmacy at King Saud University in Riyadh, Saudi Arabia.

U Rehman, Muneeb
Muneeb U Rehman (Ph.D.) is a Faculty member at College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. He holds a doctorate in Toxicology (specialization in cancer biology and natural product research) from Jamia Hamdard, New Delhi, India. Dr. Rehman has more than 10 years of research and teaching experience in the field of toxicology, cancer biology, natural product pharmacology and pharmacogenomics. He is the recipient of several national and international fellowships and awards. He has published more than 100 research papers in peer-reviewed, international journals, and has 5 edited books and 30 book chapters. Dr. Rehman is on the editorial boards and is a reviewer of several high-impact, international scientific journals. He is also a life member of various international societies and organizations. Currently, Dr. Rehman is engaged in studying the molecular mechanisms of cancer prevention by natural products and the role of pharmacogenomics and toxicogenomics in evaluating the effectiveness and safety of drugs.